179 related articles for article (PubMed ID: 16740631)
1. Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences.
Debela M; Magdolen V; Schechter N; Valachova M; Lottspeich F; Craik CS; Choe Y; Bode W; Goettig P
J Biol Chem; 2006 Sep; 281(35):25678-88. PubMed ID: 16740631
[TBL] [Abstract][Full Text] [Related]
2. Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals.
Slagter MH; Scorilas A; Gooren LJ; de Ronde W; Soosaipillai A; Giltay EJ; Paliouras M; Diamandis EP
Clin Chem; 2006 Aug; 52(8):1546-51. PubMed ID: 16777918
[TBL] [Abstract][Full Text] [Related]
3. Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender.
Komatsu N; Saijoh K; Sidiropoulos M; Tsai B; Levesque MA; Elliott MB; Takehara K; Diamandis EP
J Invest Dermatol; 2005 Dec; 125(6):1182-9. PubMed ID: 16354188
[TBL] [Abstract][Full Text] [Related]
4. Human tissue kallikrein gene family: applications in cancer.
Obiezu CV; Diamandis EP
Cancer Lett; 2005 Jun; 224(1):1-22. PubMed ID: 15911097
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site.
Debela M; Magdolen V; Grimminger V; Sommerhoff C; Messerschmidt A; Huber R; Friedrich R; Bode W; Goettig P
J Mol Biol; 2006 Oct; 362(5):1094-107. PubMed ID: 16950394
[TBL] [Abstract][Full Text] [Related]
6. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Diamandis EP; Scorilas A; Kishi T; Blennow K; Luo LY; Soosaipillai A; Rademaker AW; Sjogren M
Clin Biochem; 2004 Mar; 37(3):230-7. PubMed ID: 14972646
[TBL] [Abstract][Full Text] [Related]
7. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase.
Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K
Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417
[TBL] [Abstract][Full Text] [Related]
8. A structural model for the prostate disease marker, human prostate-specific antigen.
Villoutreix BO; Getzoff ED; Griffin JH
Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
[TBL] [Abstract][Full Text] [Related]
9. Human tissue kallikreins: a family of new cancer biomarkers.
Diamandis EP; Yousef GM
Clin Chem; 2002 Aug; 48(8):1198-205. PubMed ID: 12142373
[TBL] [Abstract][Full Text] [Related]
10. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
12. Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.
Debela M; Beaufort N; Magdolen V; Schechter NM; Craik CS; Schmitt M; Bode W; Goettig P
Biol Chem; 2008 Jun; 389(6):623-32. PubMed ID: 18627343
[TBL] [Abstract][Full Text] [Related]
13. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines.
Paliouras M; Diamandis EP
Breast Cancer Res Treat; 2007 Mar; 102(1):7-18. PubMed ID: 16897430
[TBL] [Abstract][Full Text] [Related]
14. Protein products of the rat kallikrein gene family. Substrate specificities of kallikrein rK2 (tonin) and kallikrein rK9.
Moreau T; Brillard-Bourdet M; Bouhnik J; Gauthier F
J Biol Chem; 1992 May; 267(14):10045-51. PubMed ID: 1315752
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of the zinc inhibition of human tissue kallikrein 5.
Debela M; Goettig P; Magdolen V; Huber R; Schechter NM; Bode W
J Mol Biol; 2007 Nov; 373(4):1017-31. PubMed ID: 17881000
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of human kallikreins 1 and 6 determined by phage display.
Li HX; Hwang BY; Laxmikanthan G; Blaber SI; Blaber M; Golubkov PA; Ren P; Iverson BL; Georgiou G
Protein Sci; 2008 Apr; 17(4):664-72. PubMed ID: 18359858
[TBL] [Abstract][Full Text] [Related]
17. Expanded human tissue kallikrein family--a novel panel of cancer biomarkers.
Yousef GM; Diamandis EP
Tumour Biol; 2002; 23(3):185-92. PubMed ID: 12218299
[TBL] [Abstract][Full Text] [Related]
18. Inhibition profiles of human tissue kallikreins by serine protease inhibitors.
Luo LY; Jiang W
Biol Chem; 2006 Jun; 387(6):813-6. PubMed ID: 16800745
[TBL] [Abstract][Full Text] [Related]
19. Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2.
Bourgeois L; Brillard-Bourdet M; Deperthes D; Juliano MA; Juliano L; Tremblay RR; Dubé JY; Gauthier F
J Biol Chem; 1997 Nov; 272(47):29590-5. PubMed ID: 9368023
[TBL] [Abstract][Full Text] [Related]
20. Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein.
Chen VC; Chao L; Chao J
J Biol Chem; 2000 Dec; 275(49):38457-66. PubMed ID: 10993887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
